Binding of the Promen fluorescent probe to human serum albumin. A fluorescence spectroscopic study

Chemico-Biological Interactions

Volumn 121, Issue 3, 1999, Pages 237-252

  Moreno, Fermín ^a   González Jiménez, José ^a  

^a Unidad de RMN   (Spain)

Author keywords

Binding sites; Fluorescent probes; HSA; Promen

Indexed keywords

DIAZEPAM; FLUORESCENT DYE; HUMAN SERUM ALBUMIN; NAPHTHALENE DERIVATIVE; PHENYLBUTAZONE; WARFARIN;

ARTICLE; BINDING SITE; DRUG PROTEIN BINDING; FLUORESCENCE POLARIZATION; FLUORESCENCE SPECTROSCOPY; HUMAN; SPECTROFLUOROMETRY; THERMODYNAMICS;

EID: 0344417913     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(99)00111-8     Document Type: Article

References (27)

1. Muller W.E., Wollert U. Human sewn albumin as a 'silent receptor' for drugs and endogenous substances. Pharmacology. 19:1979;56-59.
2. Yamasaki K., Maruyama T., Kragh-Hansen U., Otagiri M. Characterization of site I on human serum albumin: concept about the structure of a drug binding site. Biochim. Biophys. Acta. 1295:1996;147-157.
3. Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacol. Rev. 33:1981;17-53.
4. Weber G., Farris F.J. Synthesis and spectral properties of a hydrophobic fluorescent probe: 6-propionyl-2-(dimethylamino)naphthalene. Biochemistry. 18:1979;3075-3078.
5. Narazaki R., Maruyana T., Otagiri M. Probing the cysteine 34 residue in human serum albumin using fluorescence techniques. Biochim. Biophys. Acta. 1338:1997;275-281.
6. Sudlow G., Birkett D., Wade D.N. The characterization of two specific drug binding sites on serum albumin. Mol. Pharmacol. 11:1975;824-832.
7. Wilton D.C. The fatty acid analogue 11-(dansylamino) undecanoic acid is a fluorescent probe for the bilirubin-binding sites of albumin and not for the high affinity fatty acid-binding sites. Biochem. J. 270:1990;163-166.
8. Richieri G.V., Anel A., Kleinfeld A.M. Interactions of long-chain fatty acids and albumin: Determination of free fatty acid levels using the fluorescent probe ADIFAB. Biochemistry. 32:1993;7574-7580.
9. Kurono Y., Kushida I., Tanaka H., Ikeda K. Estearasa-like activity of human serum albumin. VIII. Reaction with amino acid p-nitrophenil esters. Chem. Pharm. Bull. 40:1992;2169-2172.
10. Catalan J., Perez P., Laynez J., García-Blanco F. Analysis of the solvent effect on the photophysics of 6-propionyl-2-dimethylaminonapthalene (PRODAN). J. Fluoresc. 4:1991;215-223.
11. González-Jiménez J., Frutos G., Cayre I., Cortijo M. Chlopheniramine binding to human serum albumin by fluorescence quenching measurements. Biochimie. 73:1991;551-556.
12. Mazzini A., Cavatorta P., Iori M., Favilla R., Sartor G. The binding of 4′(6-diamino-2-phenylindole) to bovine serum albumin. Biophys. Chem. 42:1992;101-106.
13. Scatchard G. The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51:1949;660-673.
14. González-Jiménez J. Analysis of the binding of chlorpheniramine to human serum albumin by spectroscopic techniques. Chem. Biol. Int. 91:1994;65-74.
15. Panjehshahin M.R., Bowmer C.J., Yates M.S. A pitfall in the use of double reciprocal plots to estimate the intrinsic molar fluorescence of ligands bound to albumin. Biochem. Pharmacol. 38:1989;155-159.
16. Kaneo Y., Nishikawa A., Kato Y., Kiryu S. Displacement of sulfonamides from bovine serum albumin by nonsteroid anti-inflamatory drugs. Chem. Pharm. Bull. 6:1979;1335-1342.
17. González-Jiménez J., Jacquotte H., Cayre I. Fluorescence quenching studies on binding Fluoreno-9-spiro-oxazolidinedione to human serum albumin. Chem. Biol. Interact. 84:1992;221-228.
18. Maruyana T., Link C.C., Yamasaki K., Miyoshi T., Mai T., Yamasakii M., Otagiri M. Binding of Suprofen to human serum albumin. Biochem. Pharmacol. 45(5):1993;1017-1026.
19. Kragh-Hansen U., Brennan S.O., Galliano M., Sugita O. Binding of Warfarin, Salicilate and Diazepam to genetic variations of human serum albumin with known mutations. Mol. Pharmacol. 37:1990;238-242.
20. Moreno F., Cortijo M., González-Jiménez J. The fluorescent probe Prodan characterizes the Warfarin binding site on human serum albumin. Photochem. Photobiol. 69(1):1999;8-15.
21. Carrupt P.A., Tayar N.E.L., Karleu A., Testa B. Molecular electrostatic potential for characterizing drug-biosystem interactions. Methods Enzymol. 203:1991;638-677.
22. Neméthy G., Scheraga H.A. The structure of water and hydrophobic bonding in proteins. III. The thermodynamic properties of hydrophobic bonds in proteins. J. Phys. Chem. 66:1962;1773-1778.
23. Ros P.D., Subramanian S. Thermodynamics of protein association reactions: forces contributing to stability. Biochemistry. 20:1981;3096-3102.
24. Mazumdar M., Parrack P.K., Bhattacharyya B. Interaction of Prodan with tubulin. A fluorescence spectroscopy study. Eur. J. Biochem. 204:1992;127-132.
25. Maes V., Engelborghs Y., Hoebeke J., Maras Y., Vercruyysse A. Fluorimetric analysis of the binding of warfarin to human serum albumin. Mol. Pharmacol. 21:1981;100-107.
26. Wanwimolruk S., Birkett D.J., Brooks P. Structural requirements for drug binding to site II on human serum albumin. Mol. Pharmacol. 24:1983;458-463.
27. Noctor T.A.G., Pham C.D., Kaliszan R., Wainer I.W. Stereochemical aspects of Benzodiazepine binding to humman serum albumin. I. Enantioselective high performance liquid affinity chromatographic examination of chiral and achiral binding interactions between 1,4-benzodiazepines and human serum albumin. Mol. Pharmacol. 42:1992;506-511.